Intelligence Platform
Patents
Browse 62 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11046759
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of u
granted patentUS 11035859
Compositions and methods for detecting protease activity in biological systems
granted patentUS 11028126
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods
granted patentUS 10875913
Methods of treatment using activatable anti-EGFR antibodies
granted patentUS 10800850
Therapeutic antibodies
granted patentUS 10745481
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
granted patentUS 10709799
Activatable antibodies that bind epidermal growth factor receptor and methods of use there
granted patentUS 10669339
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
granted patentUS 10669337
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of
granted patentUS 10611845
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
granted patentUS 10568977
Antibodies that bind activatable antibodies and methods of use thereof
granted patentUS 10533053
Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor
granted patentUS 10513549
Cleavage-activatable interferon-alpha proprotein
granted patentUS 10513558
Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof
granted patentUS 10336824
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
granted patentUS 10301380
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and m
granted patentUS 10261083
Compositions and methods for detecting protease activity in biological systems
granted patentUS 10233244
Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof
granted patentUS 10179817
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof
granted patentUS 10138272
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods
granted patentUS 10118961
Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
granted patentUS 10059762
Anti-EGFR activatable antibodies
granted patentUS 9889211
Activatable antibodies that bind epidermal growth factor receptor and methods of use there
granted patentUS 9737623
Antibodies that bind activatable antibodies and methods of use thereof
granted